Mounjaro®
Starting from £179.99/mo
Start journey Learn morePrivate Wegovy 2.4mg costs in the UK typically sit in the range of roughly £149–£375 per month depending on the provider and dose, as reported widely following Eli Lilly's UK list-price changes in September 2025. That figure means little on its own. What matters is what sits behind it — because semaglutide 2.4mg is a Prescription-Only Medicine, and every legitimate price must include clinical assessment by a prescriber, not just a box in the post. The NICE appraisal of semaglutide for weight management (TA875) confirmed that this medicine should be used within a clinically supervised framework. A headline number that leaves that framework out is not a bargain; it is an incomplete picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The 2.4mg weekly dose is the standard maintenance target in the Wegovy titration schedule, patients work up from 0.25mg across roughly 16 weeks under prescriber guidance. STEP 1, the pivotal phase-3 trial published in the New England Journal of Medicine, reported an average body-weight reduction of around 15% over 68 weeks at 2.4mg alongside lifestyle changes. Those results were generated in a setting of active clinical monitoring, not self-directed use.
NICE's recommendation under TA875 reflects that context: the guidance is explicit that semaglutide should be used within a specialist weight management service, for a maximum of two years, with multidisciplinary support. None of that infrastructure appears in a per-pen price. When you compare costs between providers, you are really comparing how much of that clinical framework each price actually includes, and that is where the variation becomes meaningful.
It is also worth noting that since January 2026, the MHRA's Drug Safety Update index carries a specific update on GLP-1 medicines and acute pancreatitis. A prescriber reviewing your case regularly is not a formality; it is the mechanism through which that kind of safety signal translates into real-world protection.
Here is the misconception worth naming gently: the idea that private weight-loss medicines are like booking a flight, where the lowest number wins. They are not, and the reason is structural. A POM requires a prescription, which requires a prescriber, which costs money to provide properly. When a price looks notably low, something is usually unbundled.
Common omissions in headline pricing include: the initial consultation fee (sometimes charged separately, sometimes absorbed), prescription charges layered on top of the medicine price, delivery fees that appear at checkout, and ongoing dose-review costs when you move from one pen strength to the next. Some services also apply monthly subscription fees that auto-renew even when you pause treatment. None of these items appear in the per-pen number being advertised.
There is also the question of what aftercare looks like in practice. Managing nausea at the start, knowing when to contact someone about a side effect, understanding whether a missed dose matters at your current stage, these are conversations that a price-led service may not have the resource to support. The NHS England guidance on weight management injections sets out clearly why wraparound care exists. It is not optional; it is part of what makes treatment safe and effective.
At nume, one price covers the free consultation, the prescription, the medicine, and next-working-day DPD delivery. There are no subscription fees and no auto-renewals; every repeat order is looked at again by a prescriber before anything is sent. Aftercare is available seven days a week. Current treatment pricing is shown on our treatment page.
We are not the cheapest option in the market. That is a deliberate choice, not an oversight, we would rather absorb the cost of doing things properly than compete on a figure that strips out the clinical part. If you want to understand what the full Wegovy price picture looks like across the dose schedule, that page sets it out clearly. For a closer look at what the maintenance dose specifically costs across different providers, our Wegovy 2.4mg price comparison breaks that down in detail.
Our prescribers are GPhC-registered Independent Prescribers, you can read more about our clinical oversight on the clinical team page. Every order goes through identity verification, live weight confirmation by video, and a clinical review before dispatch. Our pharmacy is GPhC-registered (premises number 9012878, verifiable on the GPhC register) and medicines are sourced through the licensed UK supply chain.
For a prescription medicine, the question is not which provider charges the least. It is which provider is giving you a genuine clinical service and a genuine product. The MHRA has flagged publicly that fake weight-loss pens have circulated online, some containing insulin rather than semaglutide, with real hospitalisations as a result. The right check before choosing any online pharmacy is the GPhC register, and price far below the market rate is one of the clearest red flags. Sellers offering these medicines without requiring a prescription from a qualified clinician, often through social media or with suspiciously large discounts, are not a cheaper version of the same thing. They are a different thing entirely.
If you are weighing up Wegovy against the wider treatment landscape, our weight-loss overview covers what is currently licensed in the UK. For questions about how individual doses are priced across the titration schedule, our Wegovy price comparison list covers every pen strength in one place. And if you are already established on a lower dose and wondering what costs look like as you move up, the Wegovy 1mg price comparison page is a useful reference for patients earlier in the titration schedule, while the 1.7mg comparison page addresses the step just before 2.4mg.
When you are ready, a free consultation with our prescribers is the natural next step, and if you would like to review how our fees sit relative to other services before booking, our Wegovy price comparison sets out what different providers are currently charging. Start your free consultation and a clinician will review your information the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.